Prediabetes breakdown: new drug combo aims to reverse blood sugar and save hearts
Disease control
Not yet recruiting
This study tests whether glucose-lowering medications (semaglutide and dapagliflozin) can reverse prediabetes and prevent early diabetes complications in people with heart disease. About 158 participants with prediabetes and coronary artery disease will receive either the drugs p…
Phase: PHASE3 • Sponsor: Michael Mæng • Aim: Disease control
Last updated May 14, 2026 12:03 UTC